Send me a link:

*Text messaging rates may apply.

 Dow Up 0.14% Nasdaq Down 0.06%

ACADIA Pharmaceuticals Inc. (ACAD)

-NasdaqGS
20.30 Down 0.32(1.55%) 3:41PM EDT - Nasdaq Real Time Price
Prev Close:20.62
Open:20.62
Bid:20.32 x 300
Ask:20.34 x 100
1y Target Est:32.67
Beta:2.79
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:20.02 - 20.62
52wk Range:15.64 - 32.00
Volume:524,595
Avg Vol (3m):2,319,480
Market Cap:2.01B
P/E (ttm):N/A
EPS (ttm):-0.56
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ACAD

Comparison

Symbol% ChgMkt Cap
ACADDown 1.55%2.01B
AZNDown 0.78%93.19B
LLYDown 0.70%68.17B
PFEDown 0.43%191.74B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2,692.46
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.80
Quarterly EPS Est (Jun-14) :-0.19
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-1.30

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback